Skip to main content
. 2013 Feb 18;9(5):683–696. doi: 10.4161/auto.23921

Table 1. Effects of IFNA2c on cell cycle, induction of autophagy and inhibition of proliferation.

  Cell line Cell cycle analysis (% of total cells) Autophagy activity factor (AAF) (mean ± SD) Growth inhibition (%)
(mean ± SD)
 
 
Apoptotic
G0/G1
S
G2/M
 
 
Group 1
Daudi
0.1 ± 0.1
42.6 ± 2.5
20.2 ± 1.0
24.8 ± 2.8
27.8 ± 8.8
66 ± 15**
Daudi + IFNA2c
0.6 ± 1.0
53.9 ± 3.8
15.3 ± 3.0
14.0 ± 6.4
T98G
5.5 ± 1.9
50.2 ± 7.7
22.4 ± 3.0
14.3 ± 1.4
27.7 ± 9.5
30 ± 8**
T98G + IFNA2c
5.7 ± 5.3
61.9 ± 14.8
14.3 ± 6.0
6.9 ± 1.6
MDA-MB-231
1.3 ± 0.3
46.0 ± 5.5
19.8 ± 2.3
22.9 ± 2.6
9.5 ± 2.1
23 ± 5***
MDA-MB-231 + IFNA2c
1.1 ± 0.6
62.8 ± 12.7
17.5 ± 3.0
18.2 ± 1.8
Group 2
HeLa S3
1.6 ± 1.4
53.3 ± 6.2
20.2 ± 1.7
16.9 ± 1.6
27.6 ± 3.6
54 ± 11***
HeLa S3 + IFNA2c
0.9 ± 1.1
37.7 ± 7.6
33.7 ± 6.6
20.4 ± 4.9
BJAB
0.3 ± 0.4
51.2 ± 10.8
24.6 ± 6.8
17.8 ± 10.3
5.3 ± 1.4
42 ± 5**
BJAB + IFNA2c
0. Nine ± 1.4
30.8 ± 8.2
42.5 ± 12.6
13.8 ± 2.0
A549
0.9 ± 0.4
56.7 ± 3.8
20.4 ± 1.0
16.6 ± 9.4
10.5 ± 0.7
24 ± 7*
A549 + IFNA2c
0.4 ± 0.2
38.3 ± 5.3
26.6 ± 6.5
17.8 ± 2.6
Group 3 U937
2.2 ± 2.0
53.6 ± 3.5
23.9 ± 1.6
17.9 ± 2.1
8.7 ± 5.3 8 ± 6 ns
U937 + IFNA2c 2.1 ± 1.4 49.1 ± 9.2 28.1 ± 1.6 17.7 ± 4.2

Different cell lines were incubated in the presence or absence of IFNA2c (3.6 ng/mL) for 48 h. To study changes in cell cycle, cells were stained with propidium iodide (PI), and signals were measured using a Cellometer image-based cytometer. To measure autophagic signals in living cells, Cellometer image-based cytometry in combination with Cyto-ID Green dye was used. To determine inhibition of proliferation, cell numbers were counted using Cellometer image-based cytometer in combination with Trypan Blue staining. Phase populations were reported as Apoptotic, G0/G1-, S- or G2/M-phase. Data shown are averages of three individual experiments, ± SD of experimental replicates. For inhibition of proliferation, we determined two-tailed p values by using a paired t-test that compared each treatment group relative to untreated control. Statistical significance was reported as follows: *p < 0.05 (significant); **p < 0.01 (very significant); ***p < 0.001 (extremely significant); ns: p > 0.05 (not significant).